167 related articles for article (PubMed ID: 16572000)
21. Short- and long-term effects of cannabinoids on the extinction of contextual fear memory in rats.
Pamplona FA; Bitencourt RM; Takahashi RN
Neurobiol Learn Mem; 2008 Jul; 90(1):290-3. PubMed ID: 18486502
[TBL] [Abstract][Full Text] [Related]
22. Endocannabinoid modulating drugs improve anxiety but not the expression of conditioned fear in a rodent model of post-traumatic stress disorder.
Vimalanathan A; Gidyk DC; Diwan M; Gouveia FV; Lipsman N; Giacobbe P; Nobrega JN; Hamani C
Neuropharmacology; 2020 Apr; 166():107965. PubMed ID: 31962287
[TBL] [Abstract][Full Text] [Related]
23. The CB1 receptor as an important mediator of hedonic reward processing.
Friemel CM; Zimmer A; Schneider M
Neuropsychopharmacology; 2014 Sep; 39(10):2387-96. PubMed ID: 24718372
[TBL] [Abstract][Full Text] [Related]
24. Glucocorticoids interact with the hippocampal endocannabinoid system in impairing retrieval of contextual fear memory.
Atsak P; Hauer D; Campolongo P; Schelling G; McGaugh JL; Roozendaal B
Proc Natl Acad Sci U S A; 2012 Feb; 109(9):3504-9. PubMed ID: 22331883
[TBL] [Abstract][Full Text] [Related]
25. 2-AG promotes the expression of conditioned fear via cannabinoid receptor type 1 on GABAergic neurons.
Llorente-Berzal A; Terzian AL; di Marzo V; Micale V; Viveros MP; Wotjak CT
Psychopharmacology (Berl); 2015 Aug; 232(15):2811-25. PubMed ID: 25814137
[TBL] [Abstract][Full Text] [Related]
26. Cannabinoids prevent the development of behavioral and endocrine alterations in a rat model of intense stress.
Ganon-Elazar E; Akirav I
Neuropsychopharmacology; 2012 Jan; 37(2):456-66. PubMed ID: 21918506
[TBL] [Abstract][Full Text] [Related]
27. Evaluation of the in vivo receptor occupancy for the behavioral effects of cannabinoids using a radiolabeled cannabinoid receptor agonist, R-[125/131I]AM2233.
Dhawan J; Deng H; Gatley SJ; Makriyannis A; Akinfeleye T; Bruneus M; Dimaio AA; Gifford AN
Synapse; 2006 Aug; 60(2):93-101. PubMed ID: 16715483
[TBL] [Abstract][Full Text] [Related]
28. Posttraining activation of CB1 cannabinoid receptors in the CA1 region of the dorsal hippocampus impairs object recognition long-term memory.
Clarke JR; Rossato JI; Monteiro S; Bevilaqua LR; Izquierdo I; Cammarota M
Neurobiol Learn Mem; 2008 Sep; 90(2):374-81. PubMed ID: 18524639
[TBL] [Abstract][Full Text] [Related]
29. Susceptibility of the adolescent brain to cannabinoids: long-term hippocampal effects and relevance to schizophrenia.
Gleason KA; Birnbaum SG; Shukla A; Ghose S
Transl Psychiatry; 2012 Nov; 2(11):e199. PubMed ID: 23188199
[TBL] [Abstract][Full Text] [Related]
30. Involvement of cannabinoid receptors in the amygdala and prefrontal cortex of rats in fear learning, consolidation, retrieval and extinction.
Kuhnert S; Meyer C; Koch M
Behav Brain Res; 2013 Aug; 250():274-84. PubMed ID: 23702112
[TBL] [Abstract][Full Text] [Related]
31. Effects of the cannabinoid CB1 receptor antagonist AM 251 on the reinstatement of nicotine-conditioned place preference by drug priming in rats.
Budzyńska B; Kruk M; Biała G
Pharmacol Rep; 2009; 61(2):304-10. PubMed ID: 19443943
[TBL] [Abstract][Full Text] [Related]
32. Cannabinoid CB1 receptors in the medial prefrontal cortex modulate the expression of contextual fear conditioning.
Lisboa SF; Reis DG; da Silva AL; Corrêa FM; Guimarães FS; Resstel LB
Int J Neuropsychopharmacol; 2010 Oct; 13(9):1163-73. PubMed ID: 20587131
[TBL] [Abstract][Full Text] [Related]
33. Effects of intra-amygdala infusion of CB1 receptor agonists on the reconsolidation of fear-potentiated startle.
Lin HC; Mao SC; Gean PW
Learn Mem; 2006; 13(3):316-21. PubMed ID: 16705137
[TBL] [Abstract][Full Text] [Related]
34. Role of different brain structures in the behavioural expression of WIN 55,212-2 withdrawal in mice.
Castañé A; Maldonado R; Valverde O
Br J Pharmacol; 2004 Aug; 142(8):1309-17. PubMed ID: 15265804
[TBL] [Abstract][Full Text] [Related]
35. Evidence for a role of GABAergic and glutamatergic signalling in the basolateral amygdala in endocannabinoid-mediated fear-conditioned analgesia in rats.
Rea K; Olango WM; Harhen B; Kerr DM; Galligan R; Fitzgerald S; Moore M; Roche M; Finn DP
Pain; 2013 Apr; 154(4):576-585. PubMed ID: 23414578
[TBL] [Abstract][Full Text] [Related]
36. Molecular mechanisms of cannabinoid protection from neuronal excitotoxicity.
Kim SH; Won SJ; Mao XO; Jin K; Greenberg DA
Mol Pharmacol; 2006 Mar; 69(3):691-6. PubMed ID: 16299067
[TBL] [Abstract][Full Text] [Related]
37. Novel cannabinoid-sensitive receptor mediates inhibition of glutamatergic synaptic transmission in the hippocampus.
Hájos N; Ledent C; Freund TF
Neuroscience; 2001; 106(1):1-4. PubMed ID: 11564411
[TBL] [Abstract][Full Text] [Related]
38. Involvement of spinal cannabinoid receptors in the antipruritic effects of WIN 55,212-2, a cannabinoid receptor agonist.
Bilir KA; Anli G; Ozkan E; Gunduz O; Ulugol A
Clin Exp Dermatol; 2018 Jul; 43(5):553-558. PubMed ID: 29424035
[TBL] [Abstract][Full Text] [Related]
39. Cannabinoid-induced changes in respiration of brain mitochondria.
Fišar Z; Singh N; Hroudová J
Toxicol Lett; 2014 Nov; 231(1):62-71. PubMed ID: 25195527
[TBL] [Abstract][Full Text] [Related]
40. Dorsolateral periaqueductal gray matter CB1 and TRPV1 receptors exert opposite modulation on expression of contextual fear conditioning.
Uliana DL; Hott SC; Lisboa SF; Resstel LB
Neuropharmacology; 2016 Apr; 103():257-69. PubMed ID: 26724373
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
